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Abstract  
 
Substance abuse is a major worldwide concern especially within specific groups such as 
females. Female drug users have characteristics and needs which are different from those 
of male drug users. This study described the characteristics of female drug users who 
sought treatment in Helsinki between 2001 and 2008 and to explore if these characteristics 
differ according to whether or not they had children under 18 years. 
  
A cross-sectional analysis was done on baseline data of 2526 clients; out of which 775 
(30.6%) were female drug users with complete information regarding their parental status, 
who sought treatment at Helsinki Deaconess Institute from 2001 to 2008. Of them, 225 
(29%) had children under 18 years of age. The data were collected by trained clinical staff 
who interviewed clients using structured questionnaire at their first visit. Chi-square test 
was used to test differences for categorical variables and Mann-Whitney test was used to 
test for differences for continuous variables. 
 
Females with children were more likely to somewhat older (P<0.001), married or 
cohabiting (P<0.001), homeless (P=0.007), unemployed (P<0.001), and living with other 
illicit drug users (P=0.014), as compared to those without children. Self-referral and 
referral to treatment by child health care services were more common among females with 
children (P<0.001). Higher proportion of females with children reported use of opiates as 
primary drugs (P<0.001), and the primary drugs were mainly used intravenously 
(P=0.001), and daily, during past month (P=0.007). However, polydrug use (P=0.607) and 
sharing of needles/syringes (P=0.945) were similar in both groups. Prevalence of hepatitis 
B and C (P=0.041 and P<0.001 respectively) were more common in females with children.  
Among females who have children, 34.2 % had their children living within the same 
household, 37.3% in foster care and 22.7% living elsewhere. 
 
This study showed that females with children had more risky drug consumption patterns, 
and were more likely to have other drug users living in the same household. This creates an 
environment which is unhealthy for their children. 
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1. INTRODUCTION 
 
Substance abuse (also called as drug abuse) is a major worldwide concern. It was estimated 
that in 2010 between 153 million and 300 million people aged 15-64 (3.4-6.6% of the 
world’s population in that age group) had used an illicit substance at least once in the 
previous year (United Nations Office on Drugs and Crime, 2012). It has also been a major 
concern in Europe, with high estimates of past year use of cannabis (23 million), cocaine 
(4 million), 3,4-methylenedioxy-N-methylamphetamine (MDMA) (‘ecstasy’, 2.6 million) 
and amphetamines (2 million) among 15-26 years old (Bühringer et al., 2009). Generally it 
is found that the initiation of use of all substances occurs during teens or early years of 
adulthood, while the use of legal substances such as tobacco and alcohol continues in much 
larger proportions with age in the same population groups (United Nations Office on Drugs 
and Crime, 2012).  
 
Because more men use drugs, people often associate drug use with men. However, drug 
using females have characteristics and experiences which are different from male drug 
users (Becker and Duffy, 2002). They are younger than their male counterparts (Evans et 
al., 2003; Breen et al., 2005; Zilberman et al., 2003) and have higher rates of morbidity 
than male users (Grella et al., 2005; Cormier et al., 2004). They are also more likely to be 
involved in many risky behaviors such as sharing of needles, injecting equipment and 
involvement in sex work (Evans et al., 2003; Montgomery et al., 2002; Miller and Neaigus, 
2001; Azim et al., 2006). 
 
Illicit drug use by mothers may lead to problems in caring for their children, and their 
children may also experience difficulties themselves (Powis, et al., 2000). These mothers 
tend to be polydrug users and they are often afraid of seeking treatment because of the risk 
of their children being taken from them (Powis et al., 2000). Children of substance-abusing 
parents are at risk of multiple problems including depression, disruptive behavior 
disorders, and low self-esteem (Pilowsky et al., 2004).  
 
Many drug abuse treatment services follow a generic approach without giving much 
recognition to the treatment needs of under-represented groups such as females, and other 
subgroups such as females with under-aged children. Several studies have been conducted 
among female drug users in general (Azim et al., 2006; Becker and Duffy, 2002; Conners 
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et al., 2006; Cormier et al., 2004; Dolan et al., 2011; Gilchrist and Taylor, 2009). However, 
only few have considered subgroups such as females with under aged children (Conners et 
al., 2003; Powis et al., 2000; Meier et al., 2004) and these studies were limited in several 
ways. In their study, Meier et al. (2004) compared male and female drug-using parents. 
Powis et al. (2000) provided a profile of 66 women opiate users with children but their 
study was limited by small sample size and lack of comparison with non-parenting women 
drug users. Although Conners et al. (2003) described the profile of caregivers (mothers, 
fathers, and grandparents) of children affected by maternal drug addiction; there was no 
comparison with women without children. The general aim of this study is to describe the 
characteristics of female drug users who sought treatment in Helsinki between 2001 and 
2008 and to explore if these characteristics differ according to whether or not they had 
children under 18 years.  
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2. LITERATURE REVIEW 
 
2.1. Substance (drug) abuse 
 
Drug abuse and its dependence is one of the major public health burdens through different 
mechanisms such as psychiatric comorbidity, crime in the society, and other risky 
behaviors like sexual activity and poor health among others (Hesse 2009; Ross et al., 
2005). According to Diagnostic and Statistical Manual of Mental Disorders fourth edition, 
to be substance dependence, there should be development of at least 3 of the following 
criteria (American Psychiatric Association, 2000):  
 Loss of control over the amount or duration of use 
 Unsuccessful attempts to control use 
 Change in usual activities as a result of use 
 Continued use despite knowledge that physical or psychological harm will result 
 Development of tolerance, necessitating larger amounts of the substance 
 Development of withdrawal symptoms when abstaining  
 
Physiologic dependence on substance varies on types of substances like opiates, 
methamphetamine which have rapid induction of physiologic dependence, while alcohol 
has more insidious onset, and other substances including marijuana have no evidence of 
physiologic dependence (Goodman and Wolff, 2013). However, drug abuse is associated 
with numerous wide ranges of early life events, circumstances and processes in a person’s 
life (Fergusson et al., 2008).  
 
2.2. Patterns of female substance abuse 
 
Female injecting drug users are more likely to be stigmatized by the society than the male 
as their activities are considered to be doubly deviant. Traditionally women are expected to 
be good wives, mothers, daughters and nurturers of families, Therefore drug using women 
are considered to be violating the social norms of behavior and make the situation more 
worst. Due to this, females are more likely to conceal their drug behavior (United Nations 
Office on Drugs and Crime, 2006). In most of the underdeveloped and developing 
countries like Bangladesh, China, Hong Kong, India and many more the situation of 
female drug users is still less well documented but it is estimated to range from 2.5 to 25% 
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(Reid and Costigan, 2002). It has been found that married women are significantly less 
likely to use substance than unmarried women and in some cases drug abuse and its 
associated behaviors may be the cause of unemployment (Havens et al., 2009).  
 
It has also been found that there is a significant difference between male and female drug 
users. Generally female drug users are younger than male counterparts (Evans et al., 2003; 
Breen et al., 2005; Zilberman et al., 2003), and they have higher rates of impact and 
morbidity than male users (Grella et al., 2005; Cormier et al., 2004). Female drug users 
have shorter progression period between first drug use and drug dependency but exhibit 
comparatively greater severity of addiction with physical and psychological reactions 
(Hernandez-Avilla et al., 2004).  
 
Female drug users are more likely to be involved in many risky behaviors, including 
sharing needles, injecting equipment and involvement in sex work than male users (Evans 
et al., 2003; Montgomery et al., 2002; Miller and Neaigus, 2001; Azim et al., 2006). 
Prostitution is regarded as even more extreme situation for female drug users as they have 
multiple sex partners and they may have higher chance of accidental overdosed drug use 
with more lifetime suicide attempts (Grella et al., 2005). At the same time there are higher 
rates of adulthood abuse among prostitutes with more stressful and degrading sex trading 
(El-Bassel et al., 2001). 
 
2.3. Parental substance abuse 
 
Parents who abuse substances are less likely to complete their parental role effectively due 
to: 
 Impairments (both physical and mental) that occur while under the influence of 
alcohol or other drugs. 
 Expenditure of often limited household resources on purchasing alcohol or other 
drugs. 
 Time spent seeking out drugs. 
 Time spent using alcohol or other drugs. (Child Welfare Information Gateway, 
2003) 
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Drug taking parents whose children lived with other family members or in care showed 
higher-risk drug-taking behavior, more recent drug use and were less likely to be in 
treatment compared with parents who retained their children (Pilowsky et al., 2001; Meier, 
et al., 2004). They demonstrate a range of potentially unfavorable drug use behaviors and 
social circumstances, but those whose children live with them, use drugs less frequently 
and live in more favorable conditions than those whose children live elsewhere (Meier, et 
al., 2004) but there is negative impact on many areas of child development due to drug-
using parents (Advisory Council on the Misuse of Drugs 2003; Barnard & McKeganey 
2004).  
 
2.4. Consequences of substance abuse in women 
 
Substance abuse during pregnancy has numerous effects which can be divided into three 
main categories (Marx et al., 2010): 
 Maternal effects 
 Effects on the course of pregnancy and delivery, and  
 Effects on fetus, newborn and developing child.  
The three categories are further summarized in the table below (Narkowicz et al., 2013):  
 
Table 1: Consequences of substance abuse in women 
 
 Tobacco smoke  Illicit drugs  Alcohol  
Women in 
reproductive 
age  
 Dysmenorrhea 
 Impairment of 
fertility  
 Menstrual disorders 
 Fertility problems 
 Poor nutrition 
 High blood pressure 
 Rapid heart beat 
 Low weight gain 
 Low self esteem 
 Sexually transmitted 
disease 
 (Human Immuno-
deficiency Virus/ 
Acquired 
Immunodeficiency 
Syndrome 
(HIV/AIDS) 
 Depression 
 Physical abuse 
 Menstrual 
disorders 
 Fertility 
problems 
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Pregnant 
women  
 Spontaneous 
abortion 
 Preterm birth 
 Pathologies of 
placenta: 
 Necrosis placenta, 
o Placenta Previa, 
o Abruption 
placenta 
o Acute 
inflammation in 
the placenta and 
umbilical cord 
Premature rupture 
of membranes 
 Premature water 
breaks 
 Reduction of 
immunity 
 Increase 
susceptibility to 
vaginal infections 
 Spontaneous abortion 
Intrauterine death 
 Placental insufficiency 
 Placenta Previa and 
abruption placenta 
 Premature rupture of 
membranes 
 Premature delivery 
 Eclampsia 
 Gestational diabetes 
 Post-partum 
hemorrhage 
 Septic 
thrombophlebitis 
Intrauterine growth 
retardation 
 Comorbid 
medical or 
psychiatric 
disorders such 
as depression, 
and social 
problems 
 Spontaneous 
abortions 
Fetus   Fetal 
malnutrition, due 
to a reduction in 
oxygen supply 
amount (less 
25%). 
 Lower birth 
weight (up to 
150–300 g less 
than children not 
exposed). 
 Elevated blood 
pressure 
 Changes to 
protein 
metabolism 
 Delay in the fetal 
lung development 
(even two times 
than in the case of 
children not 
exposed) 
 Fetal death 
 Decreased body length 
 Low birth weight 
 Decreased head 
circumference 
 Elevated blood 
pressure 
 Changes to protein 
metabolism 
 Heart defects 
 Gastroschisis and 
small intestinal 
atresias 
 Cleft lip and palate 
 Fetal alcohol 
syndrome 
 Fetal 
malformations 
 Low birth 
weight 
 Intra Uterine 
Growth 
Retardation 
(IUGR) 
 Facial 
dysmorphism 
 Cleft lip and 
palate 
Infant/Child  Attention deficit 
disorder 
 Increased risk of 
smoking in 
adulthood 
 Prematurity 
 Low Birth Weight 
 Infections 
 Small head size 
 Birth defects 
 Short stature 
Developmental 
delay 
 Microcephaly 
 Fine-motor 
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 Weaker sucking 
reflex 
 Increased risk of 
cancer 
 Attention deficit 
hyperactivity 
disorder (ADHD) 
 Learning 
disabilities 
 Respiratory 
diseases 
(bronchial 
asthma, 
bronchitis, 
pneumonia and 
sinusitis, and 
childhood-
wheezing) 
 Stunted growth 
 HIV/AIDS 
 Learning disabilities 
 Neurological problems 
 Neonatal abstinence 
syndrome 
 Respiratory distress 
syndrome 
 Congenital anomalies 
 Attention deficit 
hyperactivity disorder 
(ADHD) 
 Poor social adjustment 
Exhibit cognitive 
deficits 
dysfunction 
HIV- Human Immuno-deficiency Virus, AIDS- Acquired Immuno-deficiency Virus, 
IUGR- Intra uterine Growth Retardation, ADHD -Attention deficit hyperactivity disorder 
 
 
2.5. Effects on pregnancy and infants  
 
Exposure to drugs during pregnancy not only affects the health of the mother but also 
increases the risk of morbidity and mortality of fetus and new born. Before, it was believed 
that placenta protect fetus against exposure to toxins and xenobiotics but now it has been 
well established that placenta metabolizes and transfers large diversity of 
pharmacologically active molecules such as drugs which enter fetal bloodstream (Minnes 
et al., 2011; Slamberova, 2012) and also via mother’s milk (Narkowicz et al., 2013). 
Moreover, the ability of substance to cross the membranes depend on placental blood-flow, 
pH of maternal and fetal blood, physico-chemical characteristic of the compounds and 
protein binding capacities (Myren et al., 2007). 
 
Neonatal withdrawal syndrome (NWS) is one of the syndromes without any signs and 
symptoms seen among infants due to in-utero drug exposure. Exposure to drugs such as 
cocaine, heroin, methadone, meperidine, morphine, phenobarbital, alcohol, amphetamines, 
codeine, clomipramine, imipramine, diazepam, hydroxyzine and other selective serotonin 
inhibitors may lead to this syndrome (Kale-Çekinmez et. al., 2012).  
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In addition, children may also experience fetal anomalies, delays in infants’ gross and fine 
motor skill development (Clark 2001; Singer et al., 2004), thromboembolic events, 
infectious diseases including pericarditis, perinatal transmission of HIV and hepatitis, and 
exposure to multidrug-resistant organisms, preterm birth, placental abruption, intrauterine 
growth restrictions, and intrauterine death (Feldman et al., 2012; Chang et al., 2008), still 
birth, Sudden Infant Death Syndrome, diseases of respiratory, nervous and cardiovascular 
systems (Narkowicz et al., 2013), impaired physical growth and development, and physical 
and mental health problems (Barnard and McKeganey, 2004). 
 
Different obstetric complications such as preterm labor, miscarriage, abruption and 
postpartum hemorrhage are associated with women who are dependent on different kind of 
substances such as opiates, marijuana or alcohol. They are also at increased risk of poor 
nutrition, anemia, urinary tract infections and other infections (Narkowicz et al., 2013). 
 
Exposure to marijuana during pregnancy is also associated with multiple neonatal 
morbidities and inconsistent outcomes (Bailey et al., 2012; Van Gelder et al., 2010). 
Effects may include decrease in length of gestation; slowing of fetal growth which may 
lead to increased risk of premature birth; altered neurobehavioral performance in new born 
infants including levels of arousal, excitability, and regulation (De Moraes Barros et al., 
2006) developmental delay; decrease in executive functioning and mood disorders among 
children due to prenatal marijuana exposure (Garry et al., 2009; Gray et al., 2005; Gray et 
al., 2010).  
 
In addition, infants born from women who used cannabis during their pregnancy have been 
reported to have lower birth weights than that of infants of non-drug using mothers 
(Fergusson et al., 2002; EI-Mohandes et al., 2003). It has also been found that the negative 
impact of active or passive smoking during pregnancy on fetal growth increases with the 
duration of exposure and number of cigarettes smoked (Dejmek et al., 2002).  
 
If a mother is receiving morphine, the drug can pass to her baby both prenatally through 
placenta and postnatally through breast milk, and the drug can be seen in blood of fetus or 
newborn immediately after few minutes of its application to the mother. The level of 
morphine can even be higher in child than level in mother due to slower metabolism 
(Karch, 2002). 
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The prevalence of alcohol and drug abuse during pregnancy is increasing despite 
awareness campaigns (Hamilton, et al. 2010) and has been one of the important public 
health problem affecting both mother and growing infant (Albrecht, et al., 2011; Burns and 
Mattick, 2007). At the same time it’s complicated to determine the prevalence rates due to 
different stigma associated with prenatal use of alcohol, tobacco, and drugs, and this make 
them forthcoming for the treatment (Radcliffe, 2011). 
 
Among the children exposed to excessive prenatal alcohol in the first trimester, it was 
found that children may have problems on verbal learning and memory (Willford et al., 
2004) and if exposed in second trimester may have reduction in the reading ability of 
children (Goldschmidt et al., 2004). Another study done by O’Leary et al. (2013) on 
exposure to excessive prenatal alcohol also found similar results with lower reading score 
and writing scores if exposed on first trimester and late pregnancy respectively. Likewise, 
in the United States, prenatal alcohol exposure was the leading cause of preventable mental 
retardation and also related to behavioral, developmental and physiological deficits (Chang 
et al., 2008). 
 
A study done on outcomes of prenatal cocaine exposure among school children found that 
the prenatal cocaine exposure is not associated with any lower full-scale, verbal or 
performance Intelligence Quotient (IQ) scores of the children but associated with an 
increased risk for specific cognitive impairments (Singer et al., 2004). Moreover, cocaine 
interacts with other substances to form new substance which may be harmful to both 
mother and fetus (Mbah et al., 2012). 
 
2.6. Postpartum effects of substance abuse  
 
In most of the cases the substance-abusing mother and her children have difficulty on 
bonding with each other and are very difficult partners with each other. The substance-
abusing behavior of mother can limit a mother’s ability to emotionally connect with her 
children, to adjust his or her rhythms and behaviors, and to anticipate or follow the 
development of her children. At the same time, the substance exposed children may also 
have impaired ability to regulate his/her states of wakefulness, sleep, distress and needs 
(Pajulo et al., 2012). Similarly, the drug using behavior of mother makes it difficult to 
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differentiate the child’s need from her own and often have difficulty to anticipate and 
follow the development stages of her own children (Pajulo et al., 2006). 
 
Substance use during pregnancy makes woman vulnerable to various complications. They 
suffer from anemia due to lack of iron and folic acid deficiency, malnutrition, absorption 
abnormalities due to lesions of the liver, intestine and pancreas, peripheral neuritis due to 
thiamine depletion, hypoglycemia or magnesium deficiency, neurologic with seizures, 
psychoses, and cerebrovascular accidents (Marx et al., 2010). 
 
2.7. Effects on early childhood and later life  
 
In those families where one or both parents abuse substances, children are at risk of abuse 
(Child Welfare Information Gateway, 2003). Substance abuse by parents affects their 
children in many significant ways. Children may be the subject of multiple child 
maltreatment, removal to foster care, failed unification, maladaptive behaviors, loss of 
their parents (Thompson et al., 2013) and substance-abusing parents are less likely to 
provide their children with appropriate care and supervision, and their children often have 
unmet basic needs including nutrition and nurturing by parents (O’Connor et al., 2005; 
Child Welfare Information Gateway, 2003). A review of key articles from the past two 
decades yields a relatively long list of possible negative outcomes for children, ranging 
from cognitive developmental delays to neglect and abuse as a result of prenatal and 
postnatal exposure to parental addiction (Beard, 2010). 
 
Generally the children of alcohol and drug abuser are subjected to extreme household 
disorganization, neglectful and abusive parenting with economic hardship (Grant, 2000) 
and they are also more likely to be victim of physical, sexual, emotional abuse or neglect 
than children of non-substance-abusing parents (DeBellis et al., 2001; Dunn et al., 2002). 
They may also be exposed to different environmental risk factors which is related to 
mother being single and have small support networks, multiple partners, psychiatric illness 
and frequent relocations (Wright et al., 2009), and their  living conditions put them at high 
risk of family disruption and exposure to violence (Conners et al., 2003).  
 
It has been found that those children who are maltreated by their substance-abusing parents 
generally remain in child welfare system longer and they experience poorer outcome than 
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others (Child Welfare Information Gateway, 2003). Additionally, in relation to child 
maltreatment, it has been found that mothers of maltreated children exhibit significantly 
greater lifetime incidence of anxiety disorders, mood disorders, alcohol and/or substance 
abuse or dependency disorder, suicide attempts and two or more psychiatric disorders 
(Debellis et al., 2001). These children who were abused and neglected during their 
childhood are also at high risk of drug addiction (White and Widom, 2008; Klein et al., 
2007; Widom et al., 2006).  
 
It is obvious that mothers who are preoccupied by their addiction problem are often not 
able to provide effective parenting to their children. Study done by Berger et al., (2010), 
found that those children who live with substance-abusing parents are at high risk of poorer 
development outcomes which may be physical, intellectual, social or emotional than other 
children living with substance non-abusing parents. The overall risk of child protection 
proceedings was significantly higher in infants of drug users than infants of non-drug users 
(Street, 2004). 
 
Due to maternal substance misuse during pregnancy, child may suffer from strabismus, 
nystagmus, and other long term visual morbidity including poor binocular function and 
poor vision acuity (Cornish et al., 2013), increased rates of respiratory infections, asthma, 
ear and sinus infections (Narkowicz et al., 2013). Maternal alcoholism and parental 
substance abuse has also been associated with increased risk of sexual abuse among 
children (Putnam, 2003).  
 
Some studies found different results about maltreatment of children by their mothers who 
abuse drugs. Onigu-Otite and Belcher (2012) found that although children whose mother 
have the history of maternal drug abuse, have higher rates of neglect and abandonment but 
there is no difference in cumulative maltreatment between them and those children whose 
mother do not abuse drugs. Mersky et al. (2009) also found that there is no difference in 
physical abuse between children with and without maternal drug.  
 
2.8. Gender perspectives of substance abuse  
 
The injecting habit of male partner often promotes female drug users on using the drugs. In 
some cases due to the unequal power balance in relationship between male and female, 
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females may have greater difficulties on abstaining from drug use and the male partner 
may also discourage the female from seeking the prevention and treatment services (United 
Nations Office on Drug and Crime, 2006).  
 
Drug using problem of women have different needs which are very complex and with 
specific experiences, which are not always recognized and met by all drug treatment 
service provider (Becker and Duffy, 2002). They usually experience more psychiatric 
symptoms such as depression and anxiety disorders which require treatment (Gilchrist et 
al., 2006; Hernandez-Avilla et al., 2004), unemployment, and other more severe medical 
problems than male users (Grella et al., 2005).  
 
A study done by Pelissier and Jones (2006), found that for the assessment and treatment of 
people who are using drugs, the sex differences in attitudes of the person is one of the 
important factors to be considered. This study also found that women appear to be more 
likely to use a wider array of coping mechanisms with the choice of strategy which is 
likely to depend on a specific situation. Women were found to have higher use of social 
support, accepting responsibility, and escaping from stressful situations than male 
prisoners who use drugs.  
 
Another study performed by Powis et al. (2000), revealed that majority of women are 
polydrug users and almost all the women had had previous contact with the criminal justice 
system and almost three quarters of them had, at some time, been taken into custody, and 
two third of them were mothers and had child-care responsibility when they were taken 
into custody. At the same time they were also afraid of approaching for the treatment 
which might increase the risk of their children being taken from them. 
 
Female Injecting Drug Users (IDU) pose more risks of blood-borne and sexually 
transmitted infections.  Female IDU are more vulnerable to HIV because of their injecting 
and sexual risk behaviors but not surprisingly sex workers tend to pose more vulnerability. 
Female IDU users infected with HIV act as a bridge in the transmission to the general 
population (Azim et al., 2006). They use previously used injecting equipment after their 
male partners or friends more often than male which make them more vulnerable to HIV 
and hepatitis C (Bennett et al., 2000; Frajzyngier et al., 2007). 
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Sexual violence among injecting drug users has also been associated for greater risk of 
HIV and it has been found that female are more likely to have a history of sexual violence 
than male drug users (Braitstein et al., 2003; Miller et al., 2002).  
 
It has also been found that those women who abuse drugs or alcohol have more chances of 
having untreated psychiatric diseases and experience of intimate partner violence, 
incarceration, and homelessness than those women who do not abuse drug or alcohol 
(Hans, 1999; Havens et al., 2009).  
 
2.9. Challenges in treatment-seeking  
 
In comparison to Western world, society is less open in other parts of the world like Asia, 
Africa, Middle East and South America. Due to this, there is less exposure to drug 
treatment and women are reluctant to enter the treatment because of different 
stigmatization in these parts of the world (Dolan et al., 2011; Grella et al., 2005; Day et al., 
2006).  It has also been found that Iranian women drug users experienced higher rate of 
prevalence and low social functioning (Dolan et al., 2011) which can be possibly 
associated with high relapse to drug use and poorer treatment outcomes (Compton et al., 
2003). Greenfield (2002), also found that among the persons who have alcohol problem, 
women are less likely to seek for treatment at alcohol-specific treatment facilities than 
men.  
 
Among the various reasons behind drug using mothers to enter to treatment center, 
availability of child care service is one of them. It helps them to concentrate more on 
treatment procedures and improving their treatment attendance than worrying about their 
children (Marsh et al., 2000). It has also been found that after finishing the drug abuse 
treatment, there is significant improvement on parenting attitudes of mothers in relation to 
abuse and child neglect (Conners et al., 2006). 
 
There is a need for comprehensive treatment facility where infants and young children live 
with their mothers. This may help to increase the relation of substance-abusing mothers in 
treatment center and also to improve the birth outcomes, and help them to become more 
competent parents. The structured environment in the treatment center including substance 
abuse treatment, access to prenatal, obstetric and pediatric care facility, good nutrition, and 
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supervised abstinence from alcohol, tobacco and illicit drugs may impact on reducing risks 
for infants including death, preterm delivery and low birth weight (Clark, 2001; Albrecht et 
al., 2011).  
  
19 
 
3. OBJECTIVES OF THE STUDY 
 
3.1. General objectives 
 
To describe the characteristics of female drug users seeking treatment at a treatment center 
in Helsinki and to describe outcomes among their children. 
 
3.2. Specific objectives 
 
 To describe the general profile of Finnish female drug users  
 To compare between female drug users with and  those without children  
 To examine various outcomes among children of female drug users  
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4. METHODOLOGY 
 
4.1. Study design 
 
The study is a cross-sectional study. The study is based on “huumehoito tietokanta” 
(HUUTI, translated as drug treatment database) study which is the first large-scale 
longitudinal study of treatment seeking illicit drug abusers in Finland. The participants in 
HUUTI study were 4817 aged 11 to 65 years who sought for the drug abuse treatment 
between 1997 and 2008 at Helsinki Deaconess Institute (HDI). The HDI is a large urban 
drug abuse treatment center located in Helsinki and offers counseling and treatment 
services to illicit drug abuse clients of all ages (Onyeka et al., 2012; Onyeka et al., 2013). 
 
4.2. Study sample 
 
Although HUUTI study was done among 4817 drug users, in this particular study, data 
from 2001 to 2008 were taken for analysis. During 2001 to 2008 there were 2526 
participants and out of these participants, 824 were female participants and missing data 
for parental status of 49 women, which left us with 775 participants.. Among the 775 
female participants, 550 (70.9%) did not have any children and remaining 225 (29.1%) had 
children less than 18 years of age.  
 
4.3. Data collection 
 
The data collection for HUUTI study was done by trained clinical staff members who 
interviewed clients using structured questionnaire at their first visit. At first visit the 
demographic information and self-reported history of drug abuse was taken, treatment 
plans were drawn and clients were then assigned to various treatment modalities in 
accordance with their needs (Onyeka et al., 2012). Questionnaire was adapted from the 
European Addiction Severity Index, the Treatment Demand Indicator Protocol, and other 
questions relevant for evaluation of treatment needs and clinical monitoring of the clients 
(Onyeka et al., 2012). Information about outcomes among children of drug-using women 
was collected from data available in the HUUTI database.  
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4.4. Statistical analysis 
 
The characteristics of female drug users included their socio-demographic characteristics, 
drug use patterns, medical and psychological problems. First, these characteristics were 
analyzed to see how they differ from those of male drug users. Second, the differences 
between female drug users who have children and those without children were compared. 
The outcomes among children less than 18 years were analyzed. 
 
Study findings were presented as proportions, mean and standard deviation (SD). Chi-
square test was used to test differences for categorical variables and Mann-Whitney test 
was used to test for differences for continuous variables. The level of significance was set 
at alpha (i.e. 0.05). Statistical Package for Social Sciences (SPSS) version 21 was used for 
statistical analysis.  
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5. SIGNIFICANCE OF THE STUDY 
 
5.1. Fewer female seeking treatment 
 
Females are not always free to seek treatment for drug abuse. There may be many 
obstacles such as social stigma, lack of awareness, lack of social support, support from 
husband or any other family members. Often times they are afraid for their children that 
their children might be taken to foster care if they seek for treatment. Conducting a study 
among treatment-seekers will help us to get an overview of female drug users which will 
help us to plan preventive measures.  
 
5.2. Female sensitive treatment facility 
 
There are comparatively less treatment facilities which are based on needs of female drug 
users. There might be the issues of privacy and female friendly environment in the 
treatment centers. The findings from this study may be useful to planners and providers of 
treatment facility and policy makers for providing treatment facility services appropriate to 
female drug users. 
 
5.3. Female drug users with children might have different needs from others 
 
Females who have their children should allocate their time in caring their children and 
fulfill the needs of their children. For this they might need more money and allocate more 
time. They might have lack of sensitivity, consciousness and they might even don´t know 
the appropriate technique of taking good care for their children. They might also have 
social fear for their children due to their habit of taking drugs. Although female drug users 
have several factors that prevent them from seeking treatment, the situation is even worse 
for those women drug users with under-aged children. The reason is because the stigma is 
worse for mother since the society expects them to show examples to their families and 
they might have their children taken away from them.  
 
5.4. Children of drug using mothers face some negative consequences 
 
Due to lack of proper parenting care from drug using mothers, children might face several 
negative consequences such as lack of proper education, lack of proper guidance, lack of 
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proper food, etc. They might also face poverty. This study might reveal the negative 
consequences with children due to drug using mothers.  
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6. ETHICAL CONSIDERATION 
 
The HUUTI study was approved by research Ethics Committee of the Hospital District of 
North-Savo and the Ethics Committee of the Helsinki Deaconess Institute, the Ministry of 
Social Affairs and Health of Finland, and appropriate municipal authorities of communities 
where clients resided.  
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7. RESULTS  
 
7.1. Socio-demographic characteristics  
 
7.1.1. Socio-demographic characteristics of male and female participants  
 
The mean age of total participants in the study was 24.9 years (SD=8.36). There were more 
males (67.0%, n=1702) than females (33.0%, n=824).  More than half (54.9%, n=1387) 
were aged 15-24 years. Table 2 shows the socio-demographic characteristics of male and 
female participants. Among total male participants, half were aged 15-24 years old while 
out of total female participants more than half (63.0%, n=519) were aged 15-24 years. 
Majority of the participants (82.6%, n=1707) were unmarried and this was similar in both 
genders (χ2=10.364, P=0.16). Most participants had home addresses (79.2%, n=1971) but 
when compared by gender, more males were homeless than females (χ2=22.29, P<0.001).  
 
Most of the participants had studied till elementary school (75.0%, n=1766) and very few 
participants had gone to the university (1.8%, n=42). However, the educational status did 
not differ among males and females (χ2=0.931, P=0.818). More than half (57.0%, n=1363) 
of the total participants were unemployed while only 13.6% (n=325) were employed and 
more males were unemployed than females (χ2=17.460, P=0.001). The main source of 
income was income support (40.9%, n=811) and more females had income support than 
males (χ2=46.644, P<0.001).  There were mostly of Finnish nationality (97.7%, n=2464), 
and this was similar in both males and females (χ2=9.028, P=0.172). Most of the 
participants in both genders were from Helsinki municipality (χ2=13.54, P=0.195, Table 2). 
As shown in Table 2, more female participants (31.4%, n=172) had other illicit drug 
abusers living with them in the same household than males (χ2= 44.060, p<0.001). 
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Table 2: Socio-demographic characteristics of male and female participants  
 
Variables Sex P-
value* 
Total 
n (%) Males n (%) Females n (%) 
Age in category (n = 
2526) 
≤ 14 
15-24 
25-34 
35-44 
≥45 
Total 
 
38 (2.2) 
868 (51.0) 
518(30.4) 
210 (12.3) 
68(4.0) 
1702 (100.0) 
 
34 (4.1) 
519(63.0) 
182(22.1) 
76(9.2) 
13(1.6) 
824(100.0) 
 
<0.001 
 
72(2.9) 
1387(54.9) 
700(27.7) 
286(11.3) 
81(3.2) 
2526(100.0) 
Marital status (n=2526) 
Married or living as a 
couple 
Not married 
Separated or divorced 
Widowed 
Total 
 
 
113(8.2) 
1161(84.3) 
102(7.4) 
1(0.1) 
1377 (100.0) 
 
 
84(12.2) 
546(79.2) 
59(8.6) 
0(0.0) 
689(100.0) 
 
 
0.16 
 
 
197(9.5) 
1707(82.6) 
161(7.8) 
1(0.0) 
2526(100.0) 
Homeless (n=2490) 
No 
Yes  
Total 
 
1285(76.5) 
395(23.5) 
1680(100.0) 
 
686(84.7) 
124(15.3) 
810(100.0) 
 
<0.001 
 
1917(79.2) 
519(20.8) 
2490(100.0) 
Education (n=2355) 
Elementary school 
High school 
University  
Other 
Total  
 
1181(74.7) 
324(20.5) 
31(2.0) 
45(2.8) 
1581(100.0) 
 
585(75.6) 
156(20.2) 
11(1.4) 
22(2.8) 
774(100.0) 
 
0.818 
 
1766(75.0) 
480(20.4) 
42(1.8) 
67(2.8) 
2355(100.0) 
Employment (n=2393) 
Employed  
Unemployed 
Student 
Other 
Total 
 
222(13.8) 
957(59.3) 
291(18.0) 
144(8.9) 
1641(100.0) 
 
103(13.2) 
406(52.1) 
167(21.4) 
103(13.2) 
779(100.0) 
 
0.001 
 
325(13.6) 
1363(57.0) 
458(19.1) 
247(10.3) 
2393(100.0) 
Main source of Income 
(n=1981) 
Salary  
Pension 
Income support 
Unemployment benefit 
Other 
Total  
 
 
315(23.6) 
57(4.3) 
540(40.4) 
231(17.3) 
19314.4) 
1336(100.0) 
 
 
131(20.3) 
20(3.1) 
271(42.0) 
63(9.8) 
160(24.8) 
645(100.0) 
 
 
<0.001 
 
 
446(22.5) 
77(3.9) 
811(40.9) 
294(14.8) 
353(17.8) 
1981(100.0) 
Nationality (n=2521) 
Finnish 
Swedish 
Russian 
Estonian 
Vietnamese 
 
1653(97.2) 
1(0.1) 
17(1.0) 
11(0.6) 
4(0.2) 
 
811(98.8) 
0(0.0) 
7(0.9) 
2(0.2) 
0(0.0) 
 
0.172 
 
2464(97.7) 
1(0.0) 
24(1.0) 
13(0.5) 
4(0.2) 
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Somalian 
Other 
Total 
1(0.1) 
13(0.8) 
1700(100.0) 
0(0.0) 
1(0.1) 
821(100.0) 
1(0.0) 
14(0.6) 
2521(100.0) 
Home municipality 
(n=2522) 
Helsinki 
Espoo 
Vantaa 
Järvenpää 
Kerava 
Kirkkonummi 
Lohja 
Nurmijärvi 
Porvoo 
Hyvinkää 
Tuusula  
Total 
 
 
1165(68.6) 
269(15.8) 
124(7.3) 
11(0.6) 
24(1.4) 
29(1.7) 
19(1.1) 
21(1.2) 
24(1.4) 
7(0.4) 
5(0.3) 
1698(100.0) 
 
 
600(72.8) 
106(12.9) 
55(6.7) 
7(0.8) 
5(0.6) 
15(1.8) 
9(1.1) 
10(1.2) 
6(0.7) 
5(0.6) 
6(0.7) 
824(100.0) 
 
 
 
 
 
0.195 
 
 
1765(70.0) 
375(14.9) 
179(7.1) 
18(0.7) 
29(1.1) 
44(1.7) 
28(1.1) 
31(1.2) 
30(1.2) 
12(0.5) 
11(0.4) 
2522(100.0) 
Other drug abusers in 
household(n=1567) 
No 
Drug abuser 
Alcohol abuser 
Drug/alcohol abuser 
Total  
 
 
768(75.3) 
173(17.0) 
42(4.1) 
37(3.6) 
1020(100.0) 
 
 
342(62.5) 
172(31.4) 
20(3.7) 
12(2.4) 
547(100.0) 
 
 
 
<0.001 
 
 
1110(70.8) 
345(22.0) 
62(4.0) 
50(3.2) 
1567(100.0) 
* Chi-square test for categorical variables 
 
 
7.1.2. Socio-demographic characteristics of females with and without children 
 
The mean age of the female participants was 23.33 years (SD=±7.5, Median= 21) but more 
than half of the females were aged 15-24 years old (62.8%, n=487). Among total females, 
most of the females did not have children (66.7%, n=550) and remaining 33.3% (n=225) 
had children. Table 3 shows the socio-demographic characteristics of females with children 
and those without children. Most of the females without children (77.6%, n=427) were 
aged 15-24 years and most of those with children (46.7%, n=105) were aged 25-34 years 
(χ2=231.92, P<0.001).Almost all the female participants were Finnish (98.8%, n=763) and 
the nationality was similar among both females with children and those without children 
(χ2=1.68, P=0.640). Most of the female participants were from Helsinki (72.8%, n=564) 
and Espoo (13.0%, n=101) and there was no difference among females with children and 
those without children (χ2=7.58, P=0.669). Majority of females were unmarried (79.0%, 
n=514). However, more females with children were married or living as couple than 
females without children (χ2=101.6, P<0.001).  
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More than 80% of female participants had home address (84.4%, n=645, Table 3) and 
homelessness was more common in females with children than females without children 
(χ2=7.245, P=0.007). Only 1.5 %( n=11) of all females had university level education 
while majority had elementary school (75.3%, n=567) but there was no difference in 
education level between females with children and those without children (χ2=2.920, 
P=0.404). Over half of all the females were unemployed (52.6%, n= 398) and just only 
13.2% (n=100) were employed. Unemployment was more common among females with 
children than females without children (χ2=61.470, P<0.001). For almost half of all the 
female participants, main source of income was income support (42.4%, n=268) and 
females with children had more income support than females without children (χ2=21.21, 
P<0.001). Only few (8.2%, n=54) experienced threats of violence and this was similar 
among both females with children and those without children (χ2=2.255, P=0.133). Over 
half of all the females (62.0%, n=330) were not living with other substance abusers. 
However, among those who do, females with children were more likely to live with other 
people abusing illicit drugs (42.7%, n=61), alcohol (3.5%, n=5) or combination of illicit 
drugs and alcohol (2.8%, n=4) than those without children (χ2=10.63, P=0.014).  
 
 
 
Table 3: Socio-demographic characteristics of females with children and without 
children  
 
Variables Females P-value* Total 
n (%) Without children 
≤ 18 years  
n (%) 
With children 
≤ 18 years   
n (%) 
Age in category (n = 775) 
≤ 14 
15-24 
25-34 
35-44 
≥45 
Total 
 
29(5.3) 
427(77.6) 
69(12.5) 
22(4.0) 
3(0.5) 
550(100.0) 
 
0(0.0) 
60(26.7) 
105(46.7) 
53(23.6) 
7(3.1) 
225(100.0) 
 
<0.001 
 
29(3.7) 
487(62.8) 
174(22.5) 
75(9.7) 
10(1.3) 
775(100.0) 
Nationality (n=772) 
Finnish 
Russian 
Estonian 
Other 
Total 
 
540(98.5) 
5(0.9) 
2(0.4) 
1(0.2) 
548(100.0) 
 
223(99.6) 
1(0.4) 
0(0.0) 
0(0.0) 
224(100.0) 
 
0.640 
 
763(98.8) 
6(0.8) 
2(0.3) 
1(0.1) 
772(100.0) 
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Home Municipality (n=775) 
Helsinki 
Espoo 
Vantaa 
Järvenpää 
Kerava 
Kirkkonummi 
Lohja 
Nurmijärvi 
Porvoo 
Hyvinkää 
Tuusula 
Total  
 
404(73.5) 
73(13.3) 
35(6.4) 
5(0.9) 
3(0.5) 
7(1.3) 
6(1.1) 
7(1.3) 
2(0.4) 
4(0.7) 
4(0.7) 
550(100.0) 
 
160(71.1) 
28(12.4) 
16(7.1) 
1(0.4) 
2(0.9) 
6(2.7) 
3(1.3) 
2(0.9) 
4(1.8) 
1(0.4) 
2(0.9) 
225(100.0) 
 
0.669 
 
564(72.8) 
101(13.0) 
51(6.6) 
6(0.8) 
5(0.6) 
13(1.7) 
9(1.2) 
9(1.2) 
6(0.8) 
5(0.6) 
6(0.8) 
775(100.0) 
Marital status (n=651) 
Married or living as a couple 
Not married 
Separated or divorced 
Total 
 
41(8.8) 
413(88.4) 
13(2.8) 
467(100.0) 
 
40(21.7) 
101(54.9) 
43(23.4) 
184(100.0) 
 
<0.001 
 
81(12.4) 
514(79.0) 
56(8.6) 
651(100.0) 
Homeless (n=764) 
No 
Yes  
Total 
 
469(86.7) 
72(13.3) 
541(100.0) 
 
176(78.9) 
47(21.1) 
223(100.0) 
 
0.007 
 
645(84.4) 
119(15.6) 
764(100.0) 
Education (n=753) 
Elementary school 
High school 
University  
Other 
Total  
 
409(76.3) 
103(19.2) 
7(1.3) 
17(3.2) 
536(100.0) 
 
158(72.8) 
51(23.5) 
4(1.8) 
4(1.8) 
217(100.0) 
 
0.404 
 
567(75.3) 
154(20.5) 
11(1.5) 
21(2.8) 
753(100.0) 
Employment (n=757) 
Employed  
Unemployed 
Student 
Other** 
Total 
 
77(14.4) 
250(46.9) 
147(27.6) 
59(11.1) 
533(100.0) 
 
23(10.3) 
148(66.1) 
10(4.5) 
43(19.2) 
224(100.0) 
 
<0.001 
 
100(13.2) 
398(52.6) 
157(20.7) 
102(13.5) 
757(100.0) 
Main source of 
Income(n=632) 
Salary 
Pension 
Income support  
Unemployment benefit  
Other  
Total 
 
 
99(23.2) 
13(3.0) 
178(41.7) 
28(6.6) 
109(25.5) 
427(100.0) 
 
 
28(13.7) 
7(3.4) 
90(43.9) 
34(16.6) 
46(22.4) 
205(100.0) 
 
 
 
<0.001 
 
 
127(20.1) 
20(3.2) 
268(42.4) 
62(9.8) 
155(24.5) 
632(100.0) 
Threat of violence (n=659) 
No  
Yes  
Total  
 
439(92.8) 
34(7.2) 
473(100.0) 
 
166(89.2) 
20(10.8) 
186(100.0) 
 
0.133 
 
605(91.8) 
54(8.2) 
659(100.0) 
Other drug abusers in the 
household(n=532) 
No 
Drug abuser 
 
 
257(66.1) 
110(28.3) 
 
 
73(51.0) 
61(42.7) 
 
 
 
0.014 
 
 
330(62.0) 
171(32.1) 
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Alcohol abuser 
Drug/alcohol abuser 
Total 
13(3.3) 
9(2.3) 
389(100.0) 
5(3.5) 
4(2.8) 
143(100.0) 
18(3.4) 
13(2.4) 
532(100.0) 
* Chi-square test for categorical variables 
**Housewife/househusband =19(2.4%), retired =20(2.6) and others =64(8.2%) 
 
 
 
7.2. Treatment seeking  
 
 
7.2.1. Reasons for seeking treatment  
 
The mean age of female participants when they sought treatment for drug addiction was 
21.9 years (SD=6.5). Table 4 shows the reasons for seeking treatment by females. For most 
of the female participants, the main reason for treatment seeking was due to drug abuse 
(88.7%, n=683) and it was slightly more common among females without children 
(χ2=13.372, P=0.010). However, more females with children (9.9%, n=22) sought 
treatment for social reasons than those without children (4.8%, n=26). More than half of all 
females had previous treatment and it was similar among both women with children and 
those without children (χ2=0.893, P=0.345). One-third of both females with children and 
those without children were receiving treatment elsewhere other than Helsinki Deaconess 
but this was not statistically significant (χ2=1.418, P=0.234). More females with children 
were receiving concurrent treatment through outpatient drug abuses services compared to 
those without children (χ2= 15.58, P=0.029). Almost half (49.0%, n=377) initiated 
treatment-seeking by themselves, and compared to females without children, more than 
half of those with children (51.6%, n=115) were self-referred to treatment, 17.9% (n=40) 
were referred by child health care services, and 13.0 %( n=29) by outpatient drug services 
(χ2= 84.99, P<0.001).  
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Table 4: Reasons for seeking treatment  
* Chi-square test for categorical variables 
Variables Females P-
value* 
Total 
n (%) Without children 
≤ 18 years  
n (%) 
With children 
≤ 18 years  
n (%) 
Main reasons for seeking 
treatment(n=770) 
Abuse 
Social reasons  
Psychiatric reasons  
After treatment 
Other reasons 
Total 
 
 
486(88.8) 
26(4.8) 
11(2.0) 
1(0.2) 
23(4.2) 
547(100.0) 
 
 
197(88.3) 
22(9.9) 
1(0.4) 
0(0.0) 
3(1.3) 
223(100.0) 
 
 
 
0.010 
 
 
683(88.7) 
48(6.2) 
12(1.6) 
1(0.1) 
26(3.4) 
770(100.0) 
Previous treatment anywhere 
(n=444) 
No  
Yes  
Total  
 
 
130(41.3) 
185(58.7) 
315(100.0) 
 
 
47(36.4) 
82(63.6) 
129(100.0) 
 
 
0.345 
 
 
177(39.9) 
267(60.1) 
444(100.0) 
Treatment elsewhere (n=757) 
No 
Yes 
Total 
 
370(68.4) 
171(31.6) 
541(100.0) 
 
138(63.9) 
78(36.1) 
216(100.0) 
 
0.234 
 
508(67.1) 
249(32.9) 
757(100.0) 
Place of treatment (n=185) 
Outpatient at drug abuse services 
Inpatient at drug abuse services 
Outpatient at social/health care  
Inpatient at social/ health care 
Social/health care housing 
services 
Self-guided groups  
Health counselling service 
Other 
Total  
 
51(41.5) 
4(3.3) 
38(30.9) 
7(5.7) 
 
2(1.6) 
1(0.8) 
5(4.1) 
15(12.2) 
123(100.0) 
 
41(66.1) 
1(1.6) 
13(21.0) 
1(1.6) 
 
0(0.0) 
1(1.6) 
4(6.5) 
1(1.6) 
62(100.0) 
 
0.029 
 
92(49.7) 
5(2.7) 
51(27.6) 
8(4.3) 
 
2(1.1) 
2(1.1) 
9(4.9) 
16(8.6) 
185(100.0) 
Guidance for treatment (n=770) 
Self-guided 
Family/friends 
Health center 
Hospital 
School health care 
Police 
Outpatient at drug abuse services 
Inpatient at drug abuse services 
Child health care 
Health care counselling service 
Other social services 
Other health care 
Other 
Total 
 
262(47.9) 
130(23.8) 
2(0.4) 
19(3.5) 
9(1.6) 
3(0.5) 
37(6.8) 
3(0.5) 
21(3.8) 
2(0.4) 
25(4.6) 
13(2.4) 
21(3.8) 
547(100.0) 
 
115(51.6) 
15(6.7) 
3(1.3) 
7(3.1) 
0(0.0) 
1(0.4) 
29(13.0) 
1(0.4) 
40(17.9) 
1(0.4) 
5(2.2) 
4(1.8) 
2(0.9) 
223(100.0) 
 
 
 
<0.001 
 
377(49.0) 
145(18.8) 
5(0.6) 
26(3.4) 
9(1.2) 
4(0.5) 
66(8.6) 
4(0.5) 
61(7.9) 
3(0.4) 
30(3.9) 
17(2.2) 
23(3.0) 
770(100.0) 
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7.2.2. Trends in treatment seeking  
 
Trend in treatment seeking is presented in Figure 1a. There was a decreasing trend in the 
total number of clients who sought each year from 2001 to 2008. When compared by 
gender very fewer number of females sought treatment than males. After 2005 there was a 
decrease in treatment-seeking among males and an increase among females (Figure 1a). 
Trend in treatment-seeking among females with children and those without children is as 
shown in Figure 1b. In 2006, treatment-seeking among females with children achieved a 
peak (40.5%, n=30) and subsequently decreased to 20.5% (n=8) in 2008. Conversely, 
treatment-seeking among females without children dipped in 2006 (59.5%, n=44) and 
subsequently increased to 79.5% (n=31) in 2008 (Figure 1b). 
 
 
Figure 1a: Treatment seeking based on gender 
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Figure 1b: Treatment seeking between females with children and those without 
children 
 
 
 
 
 
7.3. Drug use characteristics  
 
 
7.3.1. Lifetime or ever drug abuse  
 
Most of the female participants were smokers (93.0%, n=677), and mean age at initiating 
smoking was 13 years (SD=2.8, Range=6 to 33). Females without children started earlier 
to smoke than females with children (13.1 vs 14.1 years, P=0.011). The mean age when 
they started alcohol consumption was 13 years (SD=2, Range=6 to 30) and females 
without children started earlier to take alcohol for the first time than females with children 
(13 vs 14 years, P<0.001). The mean age when they started first drug abuse was 16 years 
(SD=4.2, Range=8 to 44) and females without children started earlier to take drugs than 
females with children (15.1 vs 17.4 years, P<0.001).  
 
For all females the mean number of drug-free months during last year was 1.8 months 
(SD=3.14, Range=0 to12 months) but 61.0% (n=424/692) did not have any drug free 
months. Females without children had less drug free months than females with children 
(1.6 vs 2.2 months, P=0.034). Table 5 shows the lifetime or ever abuse of drugs by female 
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participants. Overall lifetime abuse of cannabis was more prevalent than other substances 
(69.2%, n=536). Compared to those without children, females with children reported 
higher proportions of lifetime abuse of opiates (54.2%, n=122) and stimulants (74.2%, 
n=167). 
 
 
Table 5: Lifetime or ever drug abuse  
 
* Chi-square test for categorical variables 
 
Variables Females P-value* Total 
n (%) Without children 
≤ 18 years   
n (%) 
With children 
≤ 18 years  
n (%) 
Smoking (n=728) 
No 
Yes  
Total 
 
37(7.1) 
481(92.9) 
518(100.0) 
 
14(6.7) 
196(93.3) 
210(100.0) 
 
0.82 
 
51(7.0) 
677(93.0) 
728(100.0) 
Alcohol (n=775) 
No 
Yes 
Total  
 
202(36.7) 
348 (63.3) 
550(100.0) 
 
109(48.4) 
116(51.6) 
225(100.0) 
 
0.003 
 
311(40.1) 
464(59.9) 
775(100.0) 
Cannabis (n=775) 
No 
Yes 
Total 
 
148(26.9) 
402(73.1) 
550(100.0) 
 
91(40.4) 
134(59.6) 
225(100.0) 
 
<0.001 
 
239(30.8) 
536(69.2) 
775(100.0) 
Medication (n=775) 
No 
Yes 
Total 
 
300(54.5) 
250(45.5) 
550(100.0) 
 
128(56.9) 
97(43.1) 
225(100.0) 
 
0.552 
 
428(55.2) 
347(44.8) 
775(100.0) 
Opiate (n=775) 
No 
Yes 
Total 
 
309(56.2) 
241(43.8) 
550(100.0) 
 
103(45.8) 
122(54.2) 
225(100.0) 
 
0.008 
 
412(53.2) 
363(46.8) 
775(100.0) 
Stimulant (n=775) 
No 
Yes 
Total 
 
187(34.0) 
363(66.0) 
550(100.0) 
 
58(25.8) 
167(74.2) 
225(100.0) 
 
0.025 
 
245(31.6) 
530(68.4) 
775(100.0) 
Hallucinogen (n=775) 
No 
Yes 
Total 
 
524(95.3) 
26(4.7) 
550(100.0) 
 
221(98.2) 
4(1.8) 
225(100.0) 
 
0.053 
 
745(96.1) 
30(3.9) 
775(100.0) 
Solvent (n=775) 
No 
Yes 
Total 
 
545(99.1) 
5(0.9) 
550(100.0) 
 
225(100.0) 
0(0.0) 
225(100.0) 
 
0.151 
 
770(99.4) 
5(0.6) 
775(100.0) 
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7.3.2. Primary drugs of abuse 
 
The mean age when female participants in the treatment center started to use primary drug 
for the first time was 17.6 years (SD=5.7). Primary drugs of abuse reported by females at 
baseline are shown in Table 6. Most of them used alcohol (28.0%, n=217), opiate (28.1%, 
n=218) and stimulant (27.9%, n=216) as primary drugs. Alcohol (30.4%, n=167) was the 
most common primary drugs among females without children whereas opiates (35.6%, 
n=80) were the most common among females with children (χ2=25.954, P<0.001). 
Regarding route of drug administration, more than half of females with children (54.8%, 
n=114) used their primary drugs intravenously compared to 39.4% (n=205) in those 
without children (χ2=16.31, P=0.001, Table 6). Of all the females (40.1%, n=296) used 
primary drugs 7 times or more per week during past month (i.e. daily use). Past month 
daily use of primary drugs was more common among females with children (χ2=12.169, 
P=0.007) than those without children.  
 
Table 6: Primary drugs of abuse  
* Chi-square test for categorical variables 
 
Variables Females  
P-value* 
Total 
n (%) Without children 
≤ 18 years  
n (%) 
With children 
≤ 18 years  
n (%) 
Primary drugs (n=775) 
Alcohol 
Opiate  
Stimulant 
Cannabis  
Medication 
Other 
Total 
 
167(30.4) 
138(25.1) 
141(25.6) 
66(12.0) 
17(3.1) 
21(3.8) 
550(100.0) 
 
50(22.2) 
80(35.6) 
75(33.3) 
13(5.8) 
6(2.7) 
1(0.4) 
225(100.0) 
 
<0.001 
 
217(28.0) 
218(28.1) 
216(27.9) 
79(10.2) 
23(3.0) 
22(2.8) 
775(100.0) 
Mode of use (728) 
Intravenous  
Smoking  
Orally 
Snorting  
Total 
 
205(39.4) 
65(12.5) 
205(39.4) 
45(8.7) 
520(100.0) 
 
114(54.8) 
13(6.3) 
68(32.7) 
13(6.3) 
208(100.0) 
 
0.001 
 
319(43.8) 
78(10.7) 
273(37.5) 
58(8.0) 
728(100.0) 
Times/week during last 
month (n=738) 
No use 
1 time/week or less 
2-6 times/week 
7 times/week or more 
Total  
 
 
31(5.9) 
133(25.3) 
158(30.1) 
203(38.7) 
525(100.0) 
 
 
19(8.9) 
30(14.1) 
71(33.3) 
93(43.7) 
213(100.0) 
 
 
0.007 
 
 
50(6.8) 
163(22.1) 
229(31.0) 
296(40.1) 
738(100.0) 
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7.3.3. Secondary drugs of abuse 
  
The mean age at initiating secondary drug by females was 16.8 years (SD=4.8). Table 7 
shows the secondary drugs abused by female participants at baseline. Cannabis was the 
most commonly used secondary drug (35.2%, n=246), followed by stimulants (18.9%, 
n=132) and medications (18.9%, n=132). There was no statistical significant difference 
between females with children and without children on the choice of secondary drugs 
(χ2=4.237, P=0.516). Oral administration was the main mode of using secondary drugs 
(40.4%, n=260), and was similar among both females with children and females without 
children (χ2=3.715, P=0.294). Overall, secondary drug was mainly used once or less 
frequently per week during past month, and this was more common among females 
without children than among females with children (χ2=15.039, P=0.002).  
 
 
Table 7: Secondary drugs of abuse  
 
* Chi-square test for categorical variables 
 
Variables Females P-value* Total 
n (%) Without children 
≤ 18 years  
n (%) 
With children 
≤ 18 years  
n (%) 
Secondary drugs (n=699) 
Cannabis 
Stimulant  
Medication  
Alcohol 
Opiate 
Other 
Total 
 
186(37.3) 
91(18.3) 
89(17.9) 
77(15.5) 
48(9.6) 
7(1.4) 
498(100.0) 
 
60(29.9) 
41(20.4) 
43(21.4) 
32(15.9) 
23(11.4) 
2(1.0) 
201(100.0) 
 
0.516 
 
246(35.2) 
132(18.9) 
132(18.9) 
109(15.6) 
71(10.2) 
9(1.3) 
699(100.0) 
Mode of use (n=643) 
Intravenous  
Smoking  
Orally 
Snorting  
Total 
 
81(17.6) 
174(37.7) 
182(39.5) 
24(5.2) 
461(100.0) 
 
40(22.0) 
57(31.3) 
78(42.9) 
7(3.8) 
182(100.0) 
 
0.294 
 
121(18.8) 
231(35.9) 
260(40.4) 
31(4.8) 
643(100.0) 
Times/week during last 
month (n=657) 
No use 
1 time/week or less 
2-6 times/week 
7 times/week or more 
Total  
 
 
62(13.2) 
189(40.3) 
127(27.1) 
91(19.4) 
469(100.0) 
 
 
47(25.0) 
57(30.3) 
51(27.1) 
33(17.6) 
188(100.0) 
 
 
0.002 
 
 
109(16.6) 
246(37.4) 
178(27.1) 
124(18.9) 
657(100.0) 
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7.3.4. Intravenous drug abuse 
 
The mean age at which female drug abusers started injecting drugs was 19.5 years 
(SD=5.2) and females without children started to use intravenous drug earlier than females 
with children (18.5 vs 21.7 years, P<0.001). Table 8 shows intravenous drug abuse among 
female participants. Lifetime abuse/ever abuse of intravenous drug was 62.2% (n=450) and 
was more common among females with children than females without children (χ2=22.28, 
P<0.001). More than half (61.3%, n=402) had used intravenous drug during past month 
and this was more common among females with children (χ2=4.609, P=0.032). The mean 
age when female participants started sharing needles and syringes was 19.2 years (SD=4.9) 
and about one third (38.4%, n=265) had ever shared needles and syringes in their lifetime. 
The sharing of needles and syringes was more common among females with children 
(χ2=9.031, P=0.003). Only few (13.7%, n=80) females shared needles and syringes on last 
month but there was no statistically significant difference among females with children and 
without children (χ2=0.005, P=0.945). 
 
Table 8: Intravenous drug abuse  
 
* Chi-square test for categorical variables 
Variables Females P-value* Total 
n (%) Without children 
≤ 18 years  
n (%) 
With children 
≤ 18 years  
n (%) 
Lifetime IV drug (n=723) 
No 
Yes 
Total 
 
224(43.1) 
296(56.9) 
520(100.0) 
 
49(24.1) 
154(75.9) 
203(100.0) 
 
<0.001 
 
273(37.8) 
450(62.2) 
723(100.0) 
Last month IV drug use 
(n=656) 
No 
Yes 
Total 
 
 
190(41.4) 
269(58.6) 
459(100.0) 
 
 
64(32.5) 
133(67.5) 
197(100.0) 
 
 
0.032 
 
 
254(38.7) 
402(61.3) 
656(100.0) 
Shared  needles and 
syringes (n=690) 
No 
Yes  
Total 
 
 
321(65.1) 
172(34.9) 
493(100.0) 
 
 
104(52.8) 
93(47.2) 
197(100.0) 
 
 
0.003 
 
 
425(61.6) 
265(38.4) 
690(100.0) 
Last month shared needles 
and syringes (n=583) 
No 
Yes 
Total  
 
 
354(86.3) 
56(13.7) 
410(100.0) 
 
 
149(86.1) 
24(13.9) 
173(100.0) 
 
 
0.945 
 
 
503(86.3) 
80(13.7) 
583(100.0) 
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7.3.5. Number of drugs used (mono and polydrug use) 
 
 
The mean number of drugs used by female participants was 3.4 drugs (SD=1.3). Table 9 
presents the number of drugs used by the females. Ninety percent of female participants 
used polydrugs, and both females with children and without children had similar pattern of 
polydrug use (χ2=0.265, P=0.607). The use of single drug (monodrug use) was not 
common in this study population.  
 
 
Table 9: Number of drugs used  
 
* Chi-square test for categorical variables 
 
 
 
7.4. Medical and psychological conditions  
 
 
The medical and psychological conditions reported by female participants are as shown in 
Table 10. Only few females had suffered from hepatitis A (4.7%, n=20) and hepatitis B 
(3.7%, n=16) but more than one-third (39.6%, n=180) had suffered from hepatitis C. 
Among females with children and without children, the prevalence of hepatitis A was 
similar (χ2=0.033, P=0.857). However, the prevalence of hepatitis B and hepatitis C was 
more among females with children (χ2=4.158, P=0.041 and χ2=18.680, P<0.001 
respectively). Very few (2.5%, n=12) females were suffering from HIV and this was 
similar among both women with children and without children (χ2=0.763, P=0.382). More 
than half of the female participants were not vaccinated with hepatitis A (61.2%, n=222) 
and hepatitis B (59.4%, n=380) and, this pattern was similar among both females with 
Variable Females P-value* Total 
n (%) Without children 
≤ 18 years  
n (%) 
With children 
≤ 18 years  
n (%) 
Number of drug (n=775) 
Mono drug 
Polydrugs  
Total 
 
52(9.5) 
498(90.5) 
550(100.0) 
 
24(10.7) 
201(89.3) 
225(100.0) 
 
0.607 
 
76(9.8) 
699(90.2) 
775(100.0) 
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children and without children for hepatitis A (χ2=2.049, P=0.152) and hepatitis B 
(χ2=2.347, P=0.125).  
 
More than half (57.7%, n=418) had psychotic symptoms while using drugs which was 
more common among females without children (χ2=4.302, P=0.038). Depressive 
symptoms were similar among both females with children and without children (χ2=2.428, 
P=0.119) whereas psychotic symptoms at the time of interview were more common among 
females without children (χ2=9.027, P=0.003). Suicidal thoughts and suicide attempts were 
similar in both groups (χ2=2.189, P=0.139 and χ2=0.586, P=0.444 respectively, Table 10).  
 
 
Table 10: Medical and psychological conditions  
 
Variables Females P-value* Total 
n (%) Without children 
≤ 18 years  
n (%) 
With children 
≤ 18 years  
n (%) 
hepatitis A (n=428) 
No 
Yes 
Total 
 
253(95.5) 
12(4.5) 
265(100.0) 
 
155(95.1) 
8(4.9) 
163(100.0) 
 
0.857 
 
408(95.3) 
20(4.7) 
428(100.0) 
hepatitis B (n=432) 
No 
Yes 
Total 
 
261(97.8) 
6(2.2) 
267(100.0) 
 
155(93.9) 
10(6.1) 
165(100.0) 
 
0.041 
 
416(96.3) 
16(3.7) 
432(100.0) 
hepatitis C (n=455) 
No 
Yes 
Total 
 
190(68.3) 
88(31.7) 
278(100.0) 
 
85(48.0) 
92(52.0) 
177(100.0) 
 
<0.001 
 
275(60.4) 
180(39.6) 
455(100.0) 
HIV (n=480) 
No 
Yes 
Total 
 
292(98.0) 
6(2.0) 
298(100.0) 
 
176(96.7) 
6(3.3) 
182(100.0) 
 
0.382 
 
468(97.5) 
12(2.5) 
480(100.0) 
hepatitis A vaccination 
(n=363) 
No 
Yes 
Total 
 
165(63.5) 
95(36.5) 
260(100.0) 
 
57(55.3) 
46(44.7) 
103(100.0) 
 
0.152 
 
222(61.2) 
141(38.8) 
363(100.0) 
hepatitis B vaccination 
(n=640) 
No 
Yes 
Total 
 
 
284(61.2) 
180(38.8) 
464(100.0) 
 
 
96(54.5) 
80(45.5) 
176(100.0) 
 
 
0.125 
 
 
380(59.4) 
260(40.6) 
640(100.0) 
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* Chi-square test for categorical variables 
 
 
7.5. Children of female drug users  
 
 
Table 11 shows the living places of children of female drug users. More than two-thirds of 
female drug users did not have children younger than 18 years (71.0%, n= 550). However, 
among the 225 females those who did, 34.2 % (n=77) had their children living with them 
in the same household, while 37.3% (n= 84) had their children living in foster care. 
 
 
Table 11: Children of female drug users  
 
Variable  Number  
(n) 
Percentage  
(%) 
Children younger than 18 years (n=225) 
In same household  
Taken to foster care 
Living elsewhere 
Other 
Total  
 
77 
84 
51 
13 
225 
 
34.2 
37.3 
22.7 
5.8 
100.0 
Psychotic symptoms when 
using drugs (n=725) 
No 
Yes 
Total 
 
 
206(39.9) 
310(60.1) 
516(100.0) 
 
 
101(48.3) 
108(51.7) 
209(100.0) 
 
 
0.038 
 
 
307(42.3) 
418(57.7) 
725(100.0) 
Psychotic symptoms at the 
moment (n=698) 
No  
Yes 
Total  
 
 
371(74.5) 
127(25.5) 
498(100.0) 
 
 
170(85.0) 
30(15.0) 
200(100.0) 
 
 
0.003 
 
 
541(77.5) 
157(22.5) 
698(100.0) 
Depressive symptoms at 
the moment (n=710) 
No 
Yes 
Total  
 
 
134(26.7) 
367(73.3) 
501(100.0) 
 
 
68(32.5) 
141(67.5) 
209(100.0) 
 
 
0.119 
 
 
202(28.5) 
508(71.5) 
710(100.0) 
Suicidal thoughts (n=699) 
No 
Yes 
Total 
 
303(61.2) 
192(38.8) 
495(100.0) 
 
137(67.2) 
67(32.8) 
204(100.0) 
 
0.139 
 
440(62.9) 
259(37.1) 
699(100.0) 
Suicide attempts (n=658) 
No 
Yes 
Total 
 
325(70.2) 
138(29.8) 
463(100.0) 
 
131(67.2) 
64(32.8) 
195(100.0) 
 
0.444 
 
456(69.3) 
202(30.7) 
658(100.0) 
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8. DISCUSSION  
 
This study examined the characteristics of parenting and non-parenting female drug users 
who sought treatment in a treatment center in Helsinki, Finland between 2001 and 2008. 
While comparing between male and female participants, it was found that more female 
participants were living with other illicit drug abusers in the same household than males. 
This may be the one reason for using more illicit drugs by the female participants. The 
females had more income support than males. Among females, although females with 
children had more income support, homelessness was more common among them than 
those without children. This could be due to their expenditure on drugs than on other 
needs. A study (Gilchrist and Taylor, 2009) also found that female drug users living with 
children are more likely to be homelessness and to be imprisoned. 
 
In this study, although the majority of females sought treatment due to their habit of drug 
abuse, social reasons was another main reason for seeking treatment and was more 
common among females who had children. Self-referred treatment seeking was also more 
common among females with children. This suggests that they were concerned about their 
drug taking behaviour and possible effects on their children. Some of them were also 
referred by child health care services and outpatient drug services. This is more likely due 
to free child health care services and financial assistance provided by government of 
Finland and, if children are not taken good care of, they can be taken to foster care 
(Ministry of Social Affairs and Health, 2013). Unlike our results, another study has shown 
that females with children are afraid of seeking for treatment because of the risk of their 
children being taken away from them (Powis et al., 2000). 
 
Throughout the study years, treatment seeking by females with children was very low 
compared to those without children. It may be because of lack of friendly environment and 
facilities for females with children at the treatment center. Very few drug treatment centers 
are based on the needs of females with children (Advisory Council on the Misuse of Drugs, 
2003). The availability of child care service in the treatment center is one of the reasons for 
drug using mothers to enter treatment (Marsh et al., 2000). Hence, drug treatment centers 
should address the needs of females with children and the needs of their children. In this 
study, treatment seeking by females with children achieved a peak in 2006 and decreased 
in 2008, and vice versa with females without children. This shows that something special 
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must have happened during this period which led to increased treatment seeking by 
females with children and decreased treatment seeking by those without children. This is a 
need for further research in order to identify factors responsible for this observed trend in 
treatment seeking among females. 
 
This study showed that females with children used more of opiates and stimulants as their 
primary drugs and they used their primary drugs daily during past month. A study by 
Powis et al., 2000, showed similar result whereby women who have children used opiates 
as primary drug. More than half of them were using primary drugs intravenously and also 
shared syringes more than females without children. This is a serious concern as 
intravenous drug use may lead to transmission of blood-borne diseases such as HIV and 
hepatitis and female drug users infected with such diseases act as a bridge in the 
transmission to the general population (Azim et al., 2006). Our study showed that females 
with children had higher prevalence of hepatitis B and hepatitis C. The lifetime abuse of 
intravenous drugs was also common among them which made them more vulnerable to 
these diseases. Hepatitis B and C can be easily transmitted from one drug users to another 
through infected syringes. Studies have  shown that females tend to use previously used 
injecting equipment which make them more vulnerable to hepatitis C (Bennett et al., 2000; 
Frajzyngier et al., 2007) and other blood transmitted diseases such as HIV(Ghimire et al., 
2013). Thus females with children had more risky drug consumption pattern than those 
without children which could cause harms to these parenting females.  Specific programs 
should be implemented in order to reduce this risky behavior and to prevent disease 
transmission. 
 
More females with children were married or living as couple than those without children. 
Unlike our findings that drug abuse was more common among married females, a study 
(Havens et al., 2009) found that married women are less likely to use drugs than unmarried 
women. Among our study population, females with children were more likely to live with 
other people abusing illicit drugs than those without children. A previous study (Gilchrist 
and Taylor, 2009) also found similar results that female drug users living with children are 
more likely to live with drug users. The explanation for this may be that they feel secure 
for themselves and for their children while living with other partners and they have easy 
access to drugs while living with drug users than non-drug users. It is possible that their 
partners may have initiated them into drug use. The drug-using male partners may also 
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discourage females from seeking treatment services (United Nations Office on Drug and 
Crime, 2006).  
 
Among the female drug users with children, one-third of their children lived in the same 
household with them and a possibly with a drug-using partner. The drug-abusing behavior 
of a mother limit her ability to emotionally connect with her children (Pajulo, et al., 2012), 
and this negatively affects the developmental stages of such children (Pajulo, et al., 2006).  
Those children living with substance-abusing parents are at high risk of poorer 
development outcomes such as physical, intellectual, and social development compared to 
children living with non-substance-abusing parents (Berger et al., 2010). They are also 
likely to be victims of physical, sexual, emotional abuse or neglect (DeBellis et al., 2001; 
Dunn et al., 2002), and at high risk of family disruption and exposure to violence (Conners 
et al., 2003). Children who were abused and neglected during their childhood are at high 
risk of developing drug addiction (White and Widom, 2008; Klein et al., 2007; Widom et 
al., 2006). It has been found that parents whose children lived elsewhere or in care reported 
higher-risk drug-taking behavior and more regular drug use (Meier et al., 2004, Pilowsky 
et al., 2001).   
 
In this study, females without children were younger than those with children and they 
started to take drugs earlier. They also reported more psychological problems than females 
with children. A previous research study has shown that females have shorter progression 
period between first drug use and drug dependency (Hernandez-Avilla et al., 2004). To 
reduce early initiation of drug use by non-parenting females, and the resultant psychotic 
problems, preventive, educational and awareness programs should be designed and 
implemented at schools and universities, and other places where young women may be 
found.  
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9. STRENGTH AND WEAKNESSES OF THE STUDY  
 
This type of study which compares drug-using behavior of females with children and those 
without children is the first in Finland, to the best of my knowledge, and there are few 
international studies in this area. The sample size of this study is very large with long 
follow-up period from 2001 to 2008. The weakness of this study is that it is only focused 
on females. However, most of drug abuse treatment programs more readily attend to the 
needs of male drug users and therefore, this study will provide useful insights which will 
help treatment providers to deal with the needs of female drug users. Another limitation is 
that this study was done in only Helsinki metropolitan area of Finland and there may be 
differences in characteristics of female drug users in other regions. So, the findings of this 
study may not be generalized to other regions of Finland. However, Helsinki metropolitan 
area has only the major drug-using problem in Finland. This type of study may not be 
possible to carry out in other regions of Finland.  Also, the study was focused on treatment 
seekers and the findings may be different from those of non-treatment seeking female drug 
users.  
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10. CONCLUSION 
 
Findings from this study have important implications for drug abuse treatment services. 
This study showed that female drug users with children had risky drug consumption 
pattern, had adverse social circumstances, and the trend in their treatment-seeking declined 
after 2006. These, in addition to living with other drug users within the same household, 
create an unhealthy environment for child rearing. Findings from this study have important 
implications for drug abuse treatment services. Providing skills to treatment-seeking 
female drug users might be necessary. Gender-sensitive approach is necessary in order to 
identify the needs of female drug users, and factors that might negatively influence their 
treatment participation and recovery from drug addiction.  
  
46 
 
11. REFERENCES 
 
Advisory Council on the Misuse of Drugs, 2003. Hidden harm: Responding to the needs of 
children of problem drug users. London (United Kingdom): Home Office.  
Albrecht, J., Lindsay, B. and Terplan, M., 2011.Effect of waiting time on substance abuse 
treatment completion in pregnant women. Journal of substance abuse treatment, 41(1), 
pp. 71-77.  
American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental 
Disorders. 4th ed. Text Revision DSM-IV-TR ed. Arlington, VA: American 
Psychiatric Association.  
Azim, T., Chowdury, E.I., Reza, M., Ahmed, M., Uddin, M.T., Khan, R., Ahmed, G., 
Rahman, M., Khandakar, I., Khan, S.I., Sack, D.A. and Strathdee, S.A., 2006. 
Vulnerability to HIV infection among sex worker and non-sex worker female 
injecting drug users in Dhaka, Bangladesh: evidence from the baseline survey of a 
cohort study. Harm reduction journal, 3, pp. 33.  
Bailey, B.A., McCook, J.G., Hodge, A. and McGrady, L., 2012. Infant birth outcomes 
among substance using women: why quitting smoking during pregnancy is just as 
important as quitting illicit drug use. Maternal and child health journal, 16(2), pp. 414-
422. 
Barnard, M. and McKeganey, N., 2004. The impact of parental problem drug use on 
children: what is the problem and what can be done to help? Addiction (Abingdon, 
England), 99(5), pp. 552-559.  
Beard, J., Biemba, G., Brooks, M.I., Costello, J., Ommerborn, M., Bresnahan, M., FlynnN, 
D. and Simon, J.L., 2010. Children of female sex workers and drug users: a review of 
vulnerability, resilience and family-centered models of care. Journal of the 
International AIDS Society, 13 Suppl 2, pp. S6-2652-13-S2-S6. 
Becker, J. and Duffy, C., 2002. Women drug users and drugs service provision Service-
level responses to engagement and retention. United Kingdom: Home Office, London 
(United Kingdom). Drugs Prevention Advisory Service. 
Bennett, G.A., Velleman, R.D., Barter, G. and Bradbury, C., 2000. Gender differences in 
sharing injecting equipment by drug users in England. AIDS Care, 12(1), pp. 77-87.  
Berger, L.M., Slack, K.S., Waldfogel, J. and Bruch, S.K., 2010. Caseworker-perceived 
caregiver substance abuse and child protective services outcomes. Child maltreatment, 
15(3), pp. 199-210. 
Blacken, P., Hendriks, V., Pozzi, G., Tempesta, E., Hartgers, C., Koeter, M., Fahrner, 
E.M., Gsellhofer, B., Kufner, H., Kokkevi, A. and Uchtenhagen, A., 1994. European 
Addiction Severity Index (EuropASI).  
47 
 
Braitstein, P., Kathy L.I., Tyndall, M., Spittal, P., Oshaughnessy, M.V., Schilder, A., 
Johnston, C., Hogg, R.S. and Schechter, M.T., 2003. Sexual violence among a cohort 
of injection drug users. Social Science and Medicine, 57(3), pp. 561-569.  
Breen, C., Roxburgh, A. and Degenhardt, L., 2005. Gender differences among regular 
injecting drug users in Sydney, Australia, 1996-2003. Drug and Alcohol Review, 
24(4), pp. 353-358.  
Bühringer, G., Farrell, M., Kraus, L., Marsden, J., Pfeiffer-Gerschel, T., Piontek, D., 
Karachaliou, K., Künzel, J. and Stillwell, G., 2009.4642. Comparative analysis of 
research into illicit drugs in the European Union (Full report). European Commission. 
Directorate General for Justice, Freedom and Security of European Commission. 
EMCDDA. 
Burns, L. and Mattick, R.P., 2007. Using population data to examine the prevalence and 
correlates of neonatal abstinence syndrome. Drug and Alcohol Review, 26(5), pp. 
487-492.  
Chang, J.C., Dado, D., Frankel, R.M., Rodriguez, K.L., Zickmund, S., Ling, B.S. and 
Arnold, R.M., 2008. When pregnant patients disclose substance use: missed 
opportunities for behavioral change counseling. Patient education and counseling, 
72(3), pp. 394-401.  
Child Welfare Information Gateway, December, 2003. Substance abuse and child 
maltreatment. U.S. Department of Health and Human Services.  
Clark, H.W., 2001. Residential substance abuse treatment for pregnant and postpartum 
women and their children: treatment and policy implications. Child welfare, 80(2), pp. 
179-198.  
Compton, W.M., Cottler, L.B., Jacobs, J.L., Ben-Abdallah, A. and Spitzagel, E.L., 2003. 
The role of psychiatric disorders in predicting drug dependence treatment outcomes. 
The American Journal of Psychiatry, 160(5), pp. 890-895.  
Conners, N.A., Bradley, R.H., Mnsell, L.W., Liu, J.Y., Roberts, T.J., Burgdorf, K. and 
Herrell, J.M., 2003. Children of Mothers with Serious Substance Abuse Problems: An 
Accumulation of Risks. American Journal of Drug and Alcohol Abuse, 29(4), pp. 743-
758.  
Conners, N.A., Grant, A., Crone, C.C. and Whiteside-Mansell, L., 2006. Substance abuse 
treatment for mothers: treatment outcomes and the impact of length of stay. Journal of 
substance abuse treatment, 31(4), pp. 447-456.  
Cormier, R.A., Dell, C.A. and Poole, N., 2004. Women and Substance Abuse Problems. 
BMC women's health, 4 Suppl 1, pp. S8.  
Day, C., Nassirimanesh, B., Shakeshaft, A. and Dolan, K., 2006. Patterns of drug use 
among a sample of drug users and injecting drug users attending a General Practice in 
Iran. Harm reduction journal, 3, pp. 2.  
48 
 
De Bellis, M.D., Broussard, E.R., Herring, D.J., Wexler, S., Mortiz, G. and Benitez, J.G., 
2001. Psychiatric co-morbidity in caregivers and children involved in maltreatment: a 
pilot research study with policy implications. Child abuse & neglect, 25(7), pp. 923-
944.  
De Mores Barros, M.C., Guinsburg, R., De Araujo Peres, C., Mitsuhiro, S., Chalem, E. and 
Laranjeira, R.R., 2006. Exposure to marijuana during pregnancy alters neurobehavior 
in the early neonatal period. The Journal of pediatrics, 149(6), pp. 781-787.  
Dejmek, J., Solansk, Y.I., Podrazilova, K. and Sram, R.J., 2002. The exposure of 
nonsmoking and smoking mothers to environmental tobacco smoke during different 
gestational phases and fetal growth. Environmental health perspectives, 110(6), pp. 
601-606.  
Dolan, K., Salimi, S., Nassirimanesh, B., Mohsenifar, S., Allsop, D. and Mokri, A., 2011. 
Characteristics of Iranian women seeking drug treatment. Journal of women's health 
(2002), 20(11), pp. 1687-1691.  
Dunn, M.G., Tarter, R.E., Mezzich, A.C., Vanyukov, M., Kirisci, L. and Kirillova, G., 
2002. Origins and consequences of child neglect in substance abuse families. Clinical 
psychology review, 22(7), pp. 1063-1090.  
El-Bassel, N., Simoni, J.M., Cooper, D.K., Gilbert, L. and Schilling, R.F., 2001. Sex 
trading and psychological distress among women on methadone. Psychology of 
Addictive Behaviors, 15(3), pp. 177-184.  
El-Mohandes, A., Herman, A.A., Nabil El-Khorazaty, M., Katta, P.S., White, D. and 
GRYLACK, L., 2003. Prenatal care reduces the impact of illicit drug use on perinatal 
outcomes. Journal of perinatology: official journal of the California Perinatal 
Association, 23(5), pp. 354-360.  
Evans, J.L., Hahn, J.A., Page-Shafer, K., Lum, P.J., Stein, E.S., Davidson, P.J. and Moss, 
A.R., 2003. Gender differences in sexual and injection risk behavior among active 
young injection drug users in San Francisco (the UFO Study). Journal of urban health: 
bulletin of the New York Academy of Medicine, 80(1), pp. 137-146.  
Feldman, H.S., Jones, K.L., Lindsay, S., Slymen, D., Klonoff-Cohen, H., Kao, K., Rao, S. 
and Chambers, C., 2012. Prenatal alcohol exposure patterns and alcohol-related birth 
defects and growth deficiencies: a prospective study. Alcoholism, Clinical and 
Experimental Research, 36(4), pp. 670-676.  
Fergusson, D.M., Boden, J.M. and Horwood, L.J., 2008. The developmental antecedents of 
illicit drug use: Evidence from a 25-year longitudinal study. Drug and alcohol 
dependence, 96(1-2), pp. 165-177.  
Fergusson, D.M., Horwood, L.J., Northstone, K. and ALSPAC Study Team. Avon 
Longitudinal Study of Pregnancy and Childhood, 2002. Maternal use of cannabis and 
pregnancy outcome. BJOG : an international journal of obstetrics and Gynecology, 
109(1), pp. 21-27.  
49 
 
Frajzyngier, V., Neaigus, A., Gyarmanthy, V.A., Miller, M. and Friedman, S.R., 2007. 
Gender differences in injection risk behaviors at the first injection episode. Drug and 
alcohol dependence, 89(2-3), pp. 145-152.  
Garry, A., Rigourd, V., Amirouche, A., Fauroux, V., Aubry, S. and Serreau, R., 2009. 
Cannabis and breastfeeding. Journal of toxicology, 2009, pp. 596149.  
Gary Reid and Genevieve Costigan, 2002. Revisiting The Hidden Epidemic - a situation 
assessment of drug use in Asia in the context of HIV/AIDS. Australia: The Centre for 
Harm Reduction, The Burnet Institute, Australia.  
Ghimire, B., Suguimoto, S.P., Zamani, S., Ono-Kihara, M. and Kihara, M., 2013. 
Vulnerability to HIV infection among female drug users in Kathmandu Valley, Nepal: 
a cross-sectional study. BMC public health, 13, pp. 1238-2458-13-1238.  
Gilchrist, G., Atkinson, J. and Gruer, L., 2006. Illicit tranquillizer use and dependence 
among female opiate users. Drug and Alcohol Review, 25(5), pp. 459-461.  
Gilchrist, G., Gruer, L. and Atkinson, J., 2005. Comparison of drug use and psychiatric 
morbidity between prostitute and non-prostitute female drug users in Glasgow, 
Scotland. Addictive Behaviors, 30(5), pp. 1019-1023.  
Gilchrist, G. and Taylor, A., 2009. Drug-using mothers: Factors associated with retaining 
care of their children. Drug and Alcohol Review, 28(2), pp. 175-185.  
Goldschmidt, L., Richardson, G.A., Cornelius, M.D. and Day, N.L., 2004. Prenatal 
marijuana and alcohol exposure and academic achievement at age 10. 
Neurotoxicology and teratology, 26(4), pp. 521-532.  
Goodman, D.J. and Wolff, K.B., 2013. Screening for substance abuse in women's health: a 
public health imperative. Journal of midwifery & women's health, 58(3), pp. 278-287.  
Grant, B.F., 2000. Estimates of US children exposed to alcohol abuse and dependence in 
the family. American Journal of Public Health, 90(1), pp. 112-115.  
Gray, K.A., Day, N.L., Leech, S. and Richardson, G.A., 2005. Prenatal marijuana 
exposure: effect on child depressive symptoms at ten years of age. Neurotoxicology 
and teratology, 27(3), pp. 439-448.  
Gray, T.R., Eiden, R.D., Leonard, K.E., Connors, G.J., Shisler, S. and Huestis, M.A., 2010. 
Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on 
neonatal growth. Clinical chemistry, 56(9), pp. 1442-1450.  
Greenfield, S.F., 2002. Women and alcohol use disorders. Harvard review of psychiatry, 
10(2), pp. 76-85.  
Grella, C.E., Scott, C.K. and Foss, M.A., 2005. Gender differences in long-term drug 
treatment outcomes in Chicago PETS. Journal of substance abuse treatment, 28 Suppl 
1, pp. S3-12.  
50 
 
Hamilton R., McGlon, L., MacKinnon, J.R., Russell, H.C., Bradnam, M.S. and Mactier, 
H., 2010. Ophthalmic, clinical and visual electrophysiological findings in children 
born to mothers prescribed substitute methadone in pregnancy. The British journal of 
ophthalmology, 94(6), pp. 696-700.  
Hans, S.L., 1999. Demographic and psychosocial characteristics of substance-abusing 
pregnant women. Clinics in perinatology, 26(1), pp. 55-74.  
Havens, J.R., Simmons, L.A., Shannon, L.M. and Hansen, W.F., 2009. Factors associated 
with substance use during pregnancy: results from a national sample. Drug and 
alcohol dependence, 99(1-3), pp. 89-95.  
Hernandez - Avila, C.A., Rounsaville, B.J. and Kranzler, H.R., 2004. Opioid-, cannabis- 
and alcohol-dependent women show more rapid progression to substance abuse 
treatment. Drug and alcohol dependence, 74(3), pp. 265-272.  
Hesse, M., 2009. Integrated psychological treatment for substance use and co-morbid 
anxiety or depression vs. treatment for substance use alone. A systematic review of 
the published literature. BMC psychiatry, 9, pp. 6-244X-9-6.  
Kale - Cekinmez, E., Mutlu, B., Yapicioglu, H., Ozlu, F., Asker, H., Mert, K., Narli, N. 
and Satar, M., 2012. Two newborns of heroin-addicted mothers suffering neonatal 
withdrawal syndrome. The Turkish journal of pediatrics, 54(4), pp. 421-424.  
Klein, H., Elifson, K.W. and Sterk, C.E., 2007. Childhood neglect and adulthood 
involvement in HIV-related risk behaviors. Child abuse & neglect, 31(1), pp. 39-53.  
Marsh, J.C., D'Aunno, T.A. and Smith, B.D., 2000. Increasing access and providing social 
services to improve drug abuse treatment for women with children. Addiction 
(Abingdon, England), 95(8), pp. 1237-1247.  
Marwick, C., 2000. NIDA seeking data on effect of fetal exposure to methamphetamine. 
JAMA : the journal of the American Medical Association, 283(17), pp. 2225-2226.  
Marx J.A. , R.S. Hockberger, R.M. Wall, J. Adams, 2010. Rosen's emergency medicine: 
concepts and clinical practice. 7th edn. Philadelphia, PA: Mosby elsevier.  
Mbah, A.K., Alio, A.P., Fombo, D.W., Bruder, K., Dagne, G. and Salihu, H.M., 2012. 
Association between cocaine abuse in pregnancy and placenta-associated syndromes 
using propensity score matching approach. Early human development, 88(6), pp. 333-
337.  
Meier, P.S., Donmall, M.C. and McElduff, P., 2004. Characteristics of drug users who do 
or do not have care of their children. Addiction (Abingdon, England), 99(8), pp. 955-
961.  
Mersky, J.P., Berger, L.M., Reynolds, A.J. and Gromoske, A.N., 2009. Risk factors for 
child and adolescent maltreatment: A longitudinal investigation of a cohort of inner-
city youth. Child maltreatment, 14(1), pp. 73-88.  
51 
 
Miller, C.L., Spittal, P.M., LaLiberte, N., Li, K., Tyndall, M.W., O'Shaughnessy, M.V. and 
Schechter, M.T., 2002. Females experiencing sexual and drug vulnerabilities are at 
elevated risk for HIV infection among youth who use injection drugs. Journal of 
acquired immune deficiency syndromes (1999), 30(3), pp. 335-341.  
Miller, M. and Neaigus, A., 2001. Networks, resources and risk among women who use 
drugs. Social science & medicine (1982), 52(6), pp. 967-978.  
Ministry of Social Affairs and Health, 2013. Child and Family Policy in Finland. Helsinki: 
Ministry of social affairs and health.  
Minnes, S., Lang, A. and Singer, L., 2011. Prenatal tobacco, marijuana, stimulant, and 
opiate exposure: outcomes and practice implications. Addiction science & clinical 
practice, 6(1), pp. 57-70.  
Montgomery, S.B., Hyde, J., De Rosa, C.J., Rohrbach, L.A., Ennett, S., Harvey, S.M., 
Clatts, M., Iverson, E. and Kipke, M.D., 2002. Gender differences in HIV risk 
behaviors among young injectors and their social network members. The American 
Journal of Drug and Alcohol Abuse, 28(3), pp. 453-475.  
Myren, M., Mose, T., Mathiesen, L. and Knudsen, L.E., 2007. The human placenta - An 
alternative for studying foetal exposure. Toxicology in Vitro, 21(7), pp. 1332-1340.  
Narkowicz, S., Plotka, J., Polkowska, Z., Biziuk, M. and Namiesnik, J., 2013. Prenatal 
exposure to substance of abuse: a worldwide problem. Environment international, 54, 
pp. 141-163.  
O'Connor, L.A., Morgenstern, J., Gibson, F. and Nakashian, M., 2005. "Nothing about me 
without me": leading the way to collaborative relationships with families. Child 
welfare, 84(2), pp. 153-170.  
O'Leary, C.M., Taylor, C., Zubrick, S.R., Kurinczuk, J.J. and Bower, C., 2013. Prenatal 
alcohol exposure and educational achievement in children aged 8-9 years. Pediatrics, 
132(2), pp. e468-75.  
Onigu-Otite, E.C. and Belcher, H.M., 2012. Maternal drug abuse history, maltreatment, 
and functioning in a clinical sample of urban children. Child abuse & neglect, 36(6), 
pp. 491-497.  
Onyeka, I.N., Beynon, C.M., Uosukainen, H., Korhonen, M.J., Ilomäki, J., Bell, J.S., 
Paasolainen, M., Tasa, N., Tiihonen, J. and Kauhanen, J., 2013. Coexisting social 
conditions and health problems among clients seeking treatment for illicit drug use in 
Finland: the HUUTI study. BMC public health, 13, pp. 380-2458-13-380.  
Onyeka, I.N., Uosukainen, H., Korhonen, M.J., Beynon, C., Bell, J.S., Ronkainen, K., 
Föhr, J., Tiihonen, J. and Kauhanen, J., 2012. Socio-demographic characteristics and 
drug abuse patterns of treatment-seeking illicit drug abusers in Finland, 1997-2008: 
The HUUTI study. Journal of Addictive Diseases, 31(4), pp. 350-362.  
52 
 
Pajulo, M., Pyykkönen, N., Kalland, M., Sinkkonen, J., Helenius, H., Punamäki, R.L. and 
Suchman, N., 2012. Substance-Abusing Mothers in Residential Treatment with their 
Babies: Importance of Pre- and Postnatal Maternal Reflective Functioning. Infant 
mental health journal, 33(1), pp. 70-81.  
Pajulo, M., Suchman, N., Kalland, M. and Mayes, L., 2006. Enhancing the Effectiveness 
of Residential Treatment for Substance Abusing Pregnant and Parenting Women: 
Focus on Maternal Reflective Functioning and Mother-Child Relationship. Infant 
mental health journal, 27(5), pp. 448.  
Pelissier, B. and Jones, N., 2006. Differences in motivation, coping style, and self-efficacy 
among incarcerated male and female drug users. Journal of substance abuse treatment, 
30(2), pp. 113-120.  
Pilowsky, D.J., Lyles, C.M., Cross, S.I., Celentano, D., Nelson, K.E. and Vlahov, D., 2001. 
Characteristics of injection drug using parents who retain their children. Drug and 
alcohol dependence, 61(2), pp. 113-122.  
Pilowsky, D.J., Zybert, P.A. and Vlahov, D., 2004. Resilient children of injection drug 
users. Journal of the American Academy of Child and Adolescent Psychiatry, 43(11), 
pp. 1372-1379.  
Powis, B., Gossop, M., Bury, C., Payne, K. and Griffiths, P., 2000. Drug-using mothers: 
Social, psychological and substance use problems of women opiate users with 
children. Drug and Alcohol Review, 19(2), pp. 171-180.  
Putnam, F.W., 2003. Ten-year research update review: Child sexual abuse. Journal of the 
American Academy of Child and Adolescent Psychiatry, 42(3), pp. 269-278.  
Radcliffe, P., 2011. Motherhood, pregnancy, and the negotiation of identity: the moral 
career of drug treatment. Social science & medicine (1982), 72(6), pp. 984-991.  
Ross, J., Teesson, M., Darke, S., Lynskey, M., Ali, R., Ritter, A. and Cooke, R., 2005. The 
characteristics of heroin users entering treatment: findings from the Australian 
treatment outcome study (ATOS). Drug and Alcohol Review, 24(5), pp. 411-418.  
Shulman, L.H., Shapira, S.R. and Hirshfield, S., 2000. Outreach developmental services to 
children of patients in treatment for substance abuse. American Journal of Public 
Health, 90(12), pp. 1930-1933.  
Singer, L.T., Minnes, S., Short, E., Arendt, R., Farkas, K., Lewis, B., Klein, N., Russ, S., 
Min, M.O. and Kirchner, H.L., 2004. Cognitive outcomes of preschool children with 
prenatal cocaine exposure. JAMA : the journal of the American Medical Association, 
291(20), pp. 2448-2456.  
Slamberova, R., 2012. Drugs in pregnancy: the effects on mother and her progeny. 
Physiological Research / Academia Scientiarum Bohemoslovaca, 61 Suppl 1, pp. 
S123-35.  
53 
 
Cornish, K., Hrabovsky, M., Scott, N.W., Myerscough, E. and Reddy, A.R., 2013. The 
short- and long-term effects on the visual system of children following exposure to 
maternal substance misuse in pregnancy. American Journal of Ophthalmology, 
156(1), pp. 190-194.  
Srirak, N., Kawichai, S., Vongchak, T., Razak, M.H., Jittiwuttikarn, J., Tovanabutra, S., 
Rungruengthanakit, K., Keawvichit, R., Beyrer, C., Wiboonatakul, K., Sripaipan, T., 
Suriyanon, V. and Celentano, D.D., 2005. HIV infection among female drug users in 
Northern Thailand. Drug and alcohol dependence, 78(2), pp. 141-145.  
Steven B. Karch, 2002. Opiates. Karch's Pathology of Drug Abuse. Boca Raton, Florida: 
CRC Press, pp. 313- 456.  
Street, K., Harrington, J., Chiang, W., Cairns, P. and Ellis, M., 2004. How great is the risk 
of abuse in infants born to drug-using mothers? Child: care, health and development, 
30(4), pp. 325-330.  
Thompson, S., Roper, C. and Peveto, L., 2013. Parenting in recovery program: participant 
responses and case examples. Child welfare, 92(1), pp. 139-157.  
United Nations Office on Drugs and Crime, 2006. HIV/AIDS prevention and care for 
female injecting drug users. Austria: United Nations Office on Drugs and Crime 
HIV/AIDS Unit.  
United Nations Office on Drugs and Crime, 2012. World Drug Report 2012. Vienna, 
Austria: United Nations Office on Drug and Crime.  
Van Gelder, M.M., Reefhuis, J., Caton, A.R., Werler, M.M., Druschel, C.M., Roeleveld, 
N. and National Birth Defects Prevention Study, 2010. Characteristics of pregnant 
illicit drug users and associations between cannabis use and perinatal outcome in a 
population-based study. Drug and alcohol dependence, 109(1-3), pp. 243-247.  
White, H.R. and Widom, C.S., 2008. Three potential mediators of the effects of child abuse 
and neglect on adulthood substance use among women. Journal of studies on alcohol 
and drugs, 69(3), pp. 337-347.  
Widom, C.S., Marmorstein, N.R. and White, H.R., 2006. Childhood victimization and 
illicit drug use in middle adulthood. Psychology of addictive behaviors: journal of the 
Society of Psychologists in Addictive Behaviors, 20(4), pp. 394-403.  
Willford, J.A., Richardson, G.A., Leech, S.L. and Day, N.L., 2004. Verbal and visuospatial 
learning and memory function in children with moderate prenatal alcohol exposure. 
Alcoholism, Clinical and Experimental Research, 28(3), pp. 497-507.  
Wright, M.O., Crawford, E. and Del Castillo, D., 2009. Childhood emotional maltreatment 
and later psychological distress among college students: the mediating role of 
maladaptive schemas. Child abuse & neglect, 33(1), pp. 59-68.  
54 
 
Zilberman, M., Tavares, H. and el-Guebaly, N., 2003. Gender similarities and differences: 
the prevalence and course of alcohol- and other substance-related disorders. Journal of 
addictive diseases, 22(4), pp. 61-74.: 61-74.  
